untitled

Hemostasis in wound healing. Sealants and tissue repair coats

Glyco 23 Against Sepsis

Neutrolide
Anti-ischemic agent

RESEARCH & DEVELOPMENT
A Magnet Company Bringing Scientists to Work Together on Challenging Technologies

Our research program began in 1999 with a partnership set up to bridge the funding and technology commercialization gap that exist between science and business. The Program expands the professional opportunities of academic-based biomedical scientists. It provides Federal, State and private industry support to academic scientists willing to collaborate in the development of challenging technologies.

Scientific Collaborators:
Maja Nowakowski, PhD
Associate Professor State University of NewYork Downstate Department of Pathology

Martin Bluth, MD, PhD
Director of Research Wayne State University

Bill LaCourse, Ph.D. Chairman and Professor of Chemistry Department of Chemistry and Biochemistry
University of Maryland Baltimore County

Aristotles Kalivretenos, PhD Chemist

Leonid Medved, Ph.D.Professor of Biochemistry and Molecular BiologyUniversity of Maryland, School of Medicine
Center for Vascular and Inflammatory Diseases
Department of Biochemistry and Molecular Biology

Jorge Fishbarg, MD Professor of Physiology Eye Instititute, School of Medicine, Columbia University, New York

Grant Bochicchio, MD PhD Professor & Director
University of Maryland Baltimore Trauma Center

Richard Sinert, MD Research Director, Emergency Medicine
SUNY Downste Medical Center

Luis Toledo Pereyra, MD PhD Professor of Surgery
Michigan State University

The development of our platform technologies is funded by:

U.S. Army Medical Research & Material Command USAMRAA

Defense Advance Research Projects Agency (DARPA)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Heart, Lung and Blood Institute (NHLBI)

National Institute of General Medical Sciences (NIGMS)

National Institute of Allergy and Infectious Diseases (NIAID)

Johnson&Johnson/COSAT

Maryland Technology Development Corporation (TEDCO)
University of Maryland

and by private investors.

hemostathemostatic-selant-frontpage.htmic-selhemostatic-selant-frontpage.htmant-frontpage.htm



Hemostasis in wound healing. Sealants and tissue repair coats Glyco 23 Against Sepsis Neutrolide Anti-ischemic agent	*RESEARCH & DEVELOPMENT* A Magnet Company Bringing Scientists to Work Together on Challenging Technologies Our research program began in 1999 with a partnership set up to bridge the funding and technology commercialization gap that exist between science and business. The Program expands the professional opportunities of academic-based biomedical scientists. It provides Federal, State and private industry support to academic scientists willing to collaborate in the development of challenging technologies. Scientific Collaborators: Maja Nowakowski, PhD Associate Professor State University of NewYork Downstate Department of Pathology Martin Bluth, MD, PhD Director of Research Wayne State University Bill LaCourse, Ph.D. Chairman and Professor of Chemistry Department of Chemistry and Biochemistry University of Maryland Baltimore County Aristotles Kalivretenos, PhD Chemist Leonid Medved, Ph.D.Professor of Biochemistry and Molecular BiologyUniversity of Maryland, School of Medicine Center for Vascular and Inflammatory Diseases Department of Biochemistry and Molecular Biology Jorge Fishbarg, MD Professor of Physiology Eye Instititute, School of Medicine, Columbia University, New York Grant Bochicchio, MD PhD Professor & Director University of Maryland Baltimore Trauma Center Richard Sinert, MD Research Director, Emergency Medicine SUNY Downste Medical Center Luis Toledo Pereyra, MD PhD Professor of Surgery Michigan State University	The development of our platform technologies is funded by: U.S. Army Medical Research & Material Command USAMRAA Defense Advance Research Projects Agency (DARPA) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Heart, Lung and Blood Institute (NHLBI) National Institute of General Medical Sciences (NIGMS) National Institute of Allergy and Infectious Diseases (NIAID) Johnson&Johnson/COSAT Maryland Technology Development Corporation (TEDCO) University of Maryland and by private investors.